SCHEMBL8261063

SCHEMBL8261063

Cn1c(CN2CCC(Nc3ccccc3N)CC2)c(Br)c(=O)n1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.39
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
BCHE P06276 2/20 0.36
ACHE P22303 1/20 0.36
DRD2 P14416 1/20 0.36
PTGS2 P35354 1/20 0.35
ROCK2 O75116 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4319479 0.80 MAPT (0.44) MAPT
SCHEMBL4318131 0.79 DRD2 (0.47) KDM4EMAPTDRD2CARM1PRMT6
SCHEMBL27692169 0.78 L3MBTL1 (0.44) KDM4EGAAMAPT
SCHEMBL4325722 0.77 CCR3 (0.52) GAACARM1PRMT6
SCHEMBL4324271 0.76 ALDH1A1 (0.48) KDM4EGAAMAPTDRD2
SCHEMBL8259826 0.76 MAPT (0.44) MAPTBCHEPTGS2
SCHEMBL4328079 0.76 DRD2 (0.43) GAAMAPTDRD2CARM1PRMT6
SCHEMBL13913957 0.75 GRM2 (0.43) KDM4EMAPTDRD2CARM1PRMT6
SCHEMBL8257304 0.75 SIGMAR1 (0.44) MAPTBCHEPTGS2
SCHEMBL13913961 0.74 PARP1 (0.41) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed